AGRX

Q: What is the price of Agile Therapeutics (AGRX) today?

The current price of Agile Therapeutics (AGRX) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Agile Therapeutics (AGRX) pay dividends?

Agile Therapeutics (AGRX) did not pay dividends over the past year.

Agile Therapeutics Inc.

This asset is no longer available for investment.

View all assets

Price

$ -

return (12m)

0.00%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

AGRX price

AGRX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment AGRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals AGRX

review the fundamentals of Agile Therapeutics shares

P/E

0.00

Sector: -1.41 Industry: 1.03

P/S (PSR)

Sector: 1.93 Industry: 2.43

P/BV

0.00

Sector: 2.07 Industry: 2.33

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-106.00%

Sector: -26.93% Industry: -26.15%

ROE

72.38%

Sector: -33.00% Industry: -35.69%

ROIC

-598.26%

Sector: -435.35% Industry: -94.66%

NET MARGIN

-73.51%

Sector: -29.11% Industry: -31.04%

GROSS MARGIN

63.62%

Sector: 45.52% Industry: 50.23%

OPERATING MARGIN

-62.86%

Sector: -23.85% Industry: -27.52%

EV/EBITDA

Sector: 0.05 Industry: 0.85

EV/EBIT

Sector: -1.20 Industry: 0.15

PRICE-TO-ASSETS

Sector: 1.14 Industry: 1.29

BVPS

-3.13

Sector: 3.93 Industry: 5.07

EPS

-2.27

Sector: -0.90 Industry: -0.69

EQUITY-TO-ASSETS RATIO

-1.46

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

-1.46

Sector: 0.47 Industry: 0.51

CAGR REVENUE 5 YEARS

39.38%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-26.69%

Sector: - Industry: -

Fundamentals AGRX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	34.89	28.27	81.02%	0.63%	$ 881.85 B	34.99%
ISRG	52.42	8.87	16.93%	0.00%	$ 156.17 B	28.15%
SNY	6.85	1.22	17.79%	5.28%	$ 102.25 B	14.75%
TMO	24.01	3.16	13.15%	0.40%	$ 164.42 B	15.15%
NVS	21.04	7.31	34.77%	2.08%	$ 284.73 B	23.92%
ABT	24.34	0.00	-%	2.78%	$ 152.79 B	13.91%
MDT	21.50	2.02	9.38%	3.67%	$ 99.20 B	13.00%
GSK	12.78	4.32	33.77%	3.52%	$ 100.27 B	17.79%
CVS	41.68	1.57	3.78%	2.77%	$ 122.20 B	0.72%
BSX	23.45	3.23	13.78%	0.00%	$ 83.60 B	17.29%
TMDX	13.51	4.70	34.80%	0.00%	$ 2.32 B	27.04%
HCA	13.94	-31.80	-228.14%	0.70%	$ 94.70 B	8.89%
IDXX	39.87	28.06	70.38%	0.00%	$ 43.66 B	24.63%
RMD	19.42	4.55	23.41%	1.14%	$ 29.51 B	27.44%
DHR	31.37	2.19	6.97%	0.83%	$ 115.73 B	14.89%
INMD	10.19	1.34	13.18%	0.00%	$ 888.30 M	23.27%
PHG	21.11	1.81	8.56%	3.54%	$ 23.86 B	5.50%
SYK	35.85	5.21	14.52%	1.10%	$ 119.63 B	13.21%
FMS	10.79	0.72	6.71%	3.64%	$ 11.88 B	4.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

AGRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Agile Therapeutics

Agile Therapeutics Inc.

Average Investor10 user rating

4.0 (4 people)

United States

29 years

Founded: 1997

2014

Time since IPO - 12 years

28

Employees

Agile Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-21.91 Millions.

The company employs approximately 28 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Agile Therapeutics Inc. reported $21.57 Millions in revenue, generating net income of $-15.86 Millions.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AGRX.

Market cap

$ -

Net worth

$ -21.91 Millions

$ -21,910,000.00

Assets

$ 14.96 Millions

$ 14,960,000.00

Total Shares Outstanding

7.00 Millions

7,000,000

Average Daily Trading Volume

$ -

Sector

Health

Industry

Pharmaceutical Products

AGRX

AGRX revenue and profits

Financial Results AGRX

DRAG THE FRAME TO SEE MORE DATA

AGRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CVS - CVS Health

$ 93.26 58,90% (12M)

P/E

41.68

2.77%

ROE

3.78%

P/BV

1.57

CI - Cigna

$ 286.24 --7,00% (12M)

P/E

11.47

2.16%

ROE

15.39%

P/BV

1.77

CNC - Centene

$ 59.14 4,84% (12M)

P/E

-4.45

0.00%

ROE

-29.93%

P/BV

1.33

HUM - Humana

$ 307.95 39,47% (12M)

P/E

32.40

1.16%

ROE

6.06%

P/BV

1.96

SNY - Sanofi

$ 44.29 --7,52% (12M)

P/E

6.85

5.28%

ROE

17.79%

P/BV

1.22

LLY - Eli Lilly

$ 1,065.00 48,20% (12M)

P/E

34.89

0.63%

ROE

81.02%

P/BV

28.27

HCA - HCA Healthcare

$ 394.07 5,54% (12M)

P/E

13.94

0.70%

ROE

-228.14%

P/BV

-31.80

NVS - Novartis

$ 152.01 37,44% (12M)

P/E

21.04

2.08%

ROE

34.77%

P/BV

7.31